Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer

Christian T.F. Freund, Mark A. Sutton, Truong Dang, Charles F. Contant, David Rowley, Seth P. Lerner

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Background. The present study tests the hypothesis that adenovirus-mediated transfer of murine IL-2 (ADV/RSV-mIL-2) alone or in combination with HSV-tk+GCV will improve antitumorigenic response in the murine MBT-2 model. Materials and Methods. mIL-2 production and toxicity were determined in vitro using an ELISA and a cell proliferation assay. Tumor-bearing animals were randomly assigned into four treatment groups and directly injected with combinations of ADV/RSV-tk and ADV/RSV-mIL-2. In a separate experiment, the above-mentioned groups were followed by two subsequent treatments with ADV/RSV-mIL-2. Results. Transduced MBT-2 cells were able to express mIL-2 in a time and dose dependent fashion. We could not demonstrate any improvement in antitumorigenic response with mIL-2 gene therapy alone or in combination with HSV-tk-suicide gene therapy over HSV-tk suicide gene therapy alone. Conclusions. Although ADV/RSV-mIL-2 transduced MBT-2 cells were able to produce large amounts of mIL-2 in vitro, we could not demonstrate significant tumor growth inhibition by adding mIL-2 gene therapy to suicide gene therapy. The growth inhibitory effects of sequential suicide and cytokine gene therapy were transient and not superior to single dose suicide and cytokine gene therapy.

Original languageEnglish (US)
Pages (from-to)1359-1365
Number of pages7
JournalAnticancer Research
Issue number3 A
StatePublished - Aug 30 2000


  • Bladder cancer
  • Cytokines
  • Gene therapy
  • IL-2

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer'. Together they form a unique fingerprint.

Cite this